Klearman Micki 4
4 · Kezar Life Sciences, Inc. · Filed Jun 17, 2022
Insider Transaction Report
Form 4
Klearman Micki
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-16+26,000→ 26,000 totalExercise: $4.80Exp: 2032-06-15→ Common Stock (26,000 underlying)
Footnotes (1)
- [F1]One-hundred percent (100%) of the shares subject to the option shall vest on 6/16/2023, subject to Reporting Person continuing to provide service through such date.